Founder of Tricycle Day 🫠
Psychonaut POV
Oct 25, 2026
[5-min read] Q&A with Stacey Armstrong, Psychologist & Researcher
Ask a Guide Anything
Oct 23, 2026
[3-min read] Facilitators unpack the significance of purging.
This Week in Psychedelics
Oct 21, 2026
[5-min read] Americans’ views on psychedelics fall into five distinct personas.
Oct 18, 2026
[5-min read] Q&A with Neil Markey, Cofounder & Army Ranger
Oct 16, 2026
[3-min read] Facilitators explain the differences between psilocybin and ayahuasca.
Oct 14, 2026
[5-min read] New study suggests LSD improves working memory in people with depression.
Oct 11, 2026
[5-min read] Q&A with Rayyan Zafar, Neuropsychopharmacologist
Oct 9, 2026
[3-min read] Facilitators consider whether psychedelics could help anxious pets.
Oct 7, 2026
[5-min read] New study ranks psychedelics by rate of adverse health outcomes.
Oct 4, 2026
[6-min read] Q&A with Bob Wold, Patient Advocate
Oct 2, 2026
[3-min read] Facilitators explain parts work and how it pairs with psychedelics.
Sep 30, 2026
[5-min read] Study suggests age moderates the relationship between psychedelic use and mental health.
Sep 27, 2026
[5-min read] Q&A with Shelagh Robinson, Psychologist & Educator
Sep 25, 2026
[3-min read] Facilitators break down how to think about dosing.
Sep 23, 2026
[5-min read] New esketamine study links dissociation to outcomes in depression.
Sep 20, 2026
[6-min read] Q&A with Jaz Cadoch, Medical Anthropologist
Sep 18, 2026
[3-min read] Facilitators refute common psychedelic wisdom.
Sep 16, 2026
[5-min read] FDA holds a public hearing on psychedelic medicine.
Sep 13, 2026
[5-min read] Q&A with Raúl Reichard, Attorney & Advocate
Sep 11, 2026
[3-min read] Facilitators explain how to ask family for support before a journey.
Sep 9, 2026
[5-min read] Psilocybin may prevent a severe side effect of chemotherapy.
Sep 6, 2026
[5-min read] Q&A with Steve Urquhart, Retired State Senator
Sep 4, 2026
[3-min read] Facilitators lay out the interactions between GLP-1s and psilocybin.
Sep 2, 2026
[5-min read] THC produces psychedelic effects in Johns Hopkins pilot study.
Aug 30, 2026
[5-min read] Q&A with Grant Ferrier, Serial Founder & Investor
